Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes.

Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes. Am Heart J. 2008 Nov; 156(5):826-32.

View in: PubMed

subject areas

Acute Coronary Syndrome
Anticholesteremic Agents
Azetidines
Double-Blind Method
Drug Combinations
Ezetimibe, Simvastatin Drug Combination
Humans
Multicenter Studies as Topic
Simvastatin
Treatment Outcome

authors with profiles

Robert Harrington